Nature Biotechnology, Published online: 20 May 2026; doi:10.1038/s41587-026-03157-6 New approaches to antivenoms for snakebite lean on cutting-edge techniques, but can they successfully be brought to market?
Post Content
SAN FRANCISCO — Former Stanford President Marc Tessier-Lavigne responded publicly for the first time Tuesday to allegations in a new book that he was forced to...
Oncogenic Signaling Shaped by a Golgi Trafficking Protein Pair
WASHINGTON — For years, the United States has poured hundreds of millions of dollars into programs to prevent and control infectious diseases in the Democratic Republic...
Virginia Gov. Abigail Spanberger has vetoed closely watched legislation to create an advisory panel to lower prescription drug costs, a setback to attempts by lawmakers across...
Researchers headed by a team at Icahn School of Medicine at Mount Sinai have discovered that many gut bacteria use a flexible survival strategy—known as epigenetic...
The Trump administration is significantly building the portfolio of drugs available through its direct-to-consumer platform TrumpRx, adding more than 600 generic medicines. President Donald Trump on...
After success with the drug Winrevair, a band of entrepreneurs has found their next challenge in a difficult-to-treat lung disease. On Tuesday, Oorja Bio launched with...
Google DeepMind and Edison Are Building the AI Scientist